COVID-19 infection. COVID-19
Conditions
Interventions
Intervention 1: Intervention group: receive 10 cc of the same 2.5% chitosan syrup (250?mg pharmacological grade chitosan) during the day, for 2 weeks.All syrups are prepared by the Barij Essence Phar
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: Age between 20 to 75 years, Willingness to participate with written informed consent, Diagnosis of coronavirus based on the PCR test.
Exclusion criteria
Exclusion criteria: Current use of warfarin, Presence of sensitivity to seafood.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Respiratory Rate. Timepoint: day 1 and day 14. Method of measurement: The number of breaths a person takes per minute.;Severity of lung involvement. Timepoint: day 1 and day 14. Method of measurement: Chest CT scan.;High-sensitivity C-reactive protein. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.;Erythrocyte Sedimentation Rate. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.;Severity and number of coughs. Timepoint: Day 1 and day 14. Method of measurement: Cough visual analogue scale (VAS).;Body temperature. Timepoint: Day 1 and day 14. Method of measurement: Clinical Thermometer.;Alanine aminotransferase Activity. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.;Aspartate aminotransferase Activity. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.;Superoxide dismutase Activity. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.;Albumin. Timepoint: Day 1 and day 14. Method of measurement: Colorimetric method.;Death outcome. Timepoint: Day 14. Method of measurement: Percentage of fatal patients in two groups. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamid Abtahi
Arak University of Medical Sciences
Outcome results
None listed